Mengling Liu

180 Fenglin Road
Zhongshan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Correction: Multi-omics reveals gut microbiome- and metabolome-specific responses to sugar alcohols.

Correction: Multi-omics reveals gut microbiome- and metabolome-specific responses to sugar alcohols.

Journal: Food & function

Published: May 01, 2026

Multi-omics reveals gut microbiome- and metabolome-specific responses to sugar alcohols.

Multi-omics reveals gut microbiome- and metabolome-specific responses to sugar alcohols.

Journal: Food & function

Published: April 17, 2026

Cyclometalated Iridium(III) Complexes with eDNA-Degrading Activity for Combating Gram-Positive Bacterial Biofilms.

Cyclometalated Iridium(III) Complexes with eDNA-Degrading Activity for Combating Gram-Positive Bacterial Biofilms.

Journal: ACS infectious diseases

Published: March 11, 2026

Targeting ATF3-mediated asparagine biosynthesis reverses acquired resistance to KRASG12C inhibitors.

Targeting ATF3-mediated asparagine biosynthesis reverses acquired resistance to KRASG12C inhibitors.

Journal: Oncogene

Published: December 28, 2025

SLC30 (ZnT) and SLC39 (ZIP) zinc transporter families: from gatekeepers of zinc homeostasis to promoters of tumorigenesis and targets for clinical therapy.

SLC30 (ZnT) and SLC39 (ZIP) zinc transporter families: from gatekeepers of zinc homeostasis to promoters of tumorigenesis and targets for clinical therapy.

Journal: Frontiers in immunology

Published: November 20, 2025

Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study.

Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study.

Journal: The oncologist

Published: July 27, 2025

Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies.

Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 01, 2025

Establishment and characterization of a patient-derived metastatic extraskeletal Ewing sarcoma cell line ES-ZSS-1.

Establishment and characterization of a patient-derived metastatic extraskeletal Ewing sarcoma cell line ES-ZSS-1.

Journal: Human cell

Published: July 10, 2024

Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: a multi-center observational study.

Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: a multi-center observational study.

Journal: Journal of translational medicine

Published: June 17, 2024

Prostate cancer-associated transcript 6 (PCAT6) promotes epithelial-mesenchymal transition and stemness and worsens prognosis in patients with colorectal cancer.

Prostate cancer-associated transcript 6 (PCAT6) promotes epithelial-mesenchymal transition and stemness and worsens prognosis in patients with colorectal cancer.

Journal: Acta biochimica et biophysica Sinica

Published: April 12, 2024

Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment.

Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment.

Journal: Critical reviews in oncology/hematology

Published: April 02, 2024

Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness.

Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 09, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026